Background
Methods
Search strategies
Search terms
Types of studies and participants
Identification of studies
Data extraction and management
Assessment of methodological quality
Data analysis
Results
Overview of the studies
Characteristic | Number of studies | Citations | % |
---|---|---|---|
Study regiona | |||
EAP | 28 | 25.9 | |
ECA | 20 | 18.5 | |
LAC | 18 | 16.7 | |
MNA | 12 | 11.1 | |
SAS | 10 | 9.25 | |
SSA | 18 | 16.7 | |
Multiple study regions | 2 | 1.85 | |
World Bank income groupb | |||
LIC | 5 | 4.63 | |
LMC | 19 | 17.6 | |
UMC | 80 | 74.1 | |
Multiple income groups | 4 | 3.70 | |
Location | |||
Urban | 18 | 16.7 | |
Peri-urban | 1 | [85] | 0.93 |
Rural | 4 | 3.70 | |
Both urban and rural | 21 | 19.4 | |
Multiple | 3 | 2.78 | |
Not available | 61 | 56.5 | |
Study setting | |||
Clinic based | 7 | 6.48 | |
Community based | 18 | 16.7 | |
Hospital based | 34 | 31.5 | |
School based | 27 | 25 | |
Others | 22 | 20.4 | |
Substance (dimension) | |||
Intoxication | 7 | 6.5 | |
Use | 52 | 48.2 | |
Pathological use (i.e., Misuse, Abuse, Addiction, Dependence, Disorder) | 68 | 63 | |
Suicide (dimension group) | |||
Suicidal ideation | 43 | 39.8 | |
Nonfatal suicidal behaviour | 73 | 67.6 | |
Fatal suicide | 11 | 10.2 |
Substance | Substance use dimension | Suicidal Ideation | NFSB | Fatal suicide |
---|---|---|---|---|
Alcohol | Intoxication | 7 | 2 | 2 |
Use | 18 (4 low-quality) | 23 (4 low-quality) | 0 | |
Pathological use | 11 | 28 (2 low-quality) | 7 (2 low-quality) | |
Tobacco | Intoxication | 0 | 0 | 0 |
Use | 18 (4 low-quality) | 22 (3 low-quality) | 0 | |
Pathological use | 8 (2 low-quality) | 10 (1 low-quality) | 0 | |
Cannabis | Intoxication | 0 | 0 | 0 |
Use | 5 (2 low-quality) | 6 (1 low-quality) | 0 | |
Pathological use | 1 | 2 | 0 | |
Cannabis and Mandrax | Intoxication | 0 | 0 | 0 |
Use | 0 | 1 | 0 | |
Pathological use | 0 | 0 | 0 | |
Opioid | Intoxication | 0 | 0 | 0 |
Use | 1 | 4 | 0 | |
Pathological use | 0 | 1 | 0 | |
Sedatives | Intoxication | 0 | 0 | 0 |
Use | 3 (1 low-quality) | 4 (1 low-quality) | 0 | |
Pathological use | 1 | 1 | 0 | |
Stimulants | Intoxication | 0 | 0 | 0 |
Use | 0 | 4 | 0 | |
Pathological use | 0 | 0 | 0 | |
Unspecified prescription medication | Intoxication | 0 | 0 | 0 |
Use | 2 | 2 | 0 | |
Pathological use | 0 | 0 | 0 | |
Stimulants | Intoxication | 0 | 0 | 0 |
Use | 0 | 4 | 0 | |
Pathological use | 0 | 0 | 0 | |
Inhalants | Intoxication | 0 | 0 | 0 |
Use | 0 | 1 | 0 | |
Pathological use | 1 | 1 | 0 | |
Hallucinogens | Intoxication | 0 | 0 | 0 |
Intoxication | 0 | 2 | 0 | |
Use | 0 | 0 | 0 | |
Unspecified substance | Intoxication | 0 | 1 | 0 |
Use | 15 (2 low-quality) | 11 (3 low-quality) | 0 | |
Pathological use | 10 (1 low-quality) | 30 (8 low-quality) | 4 |
Substance use dimension | Suicide dimension | Analysis | Association between substances and suicide | ||||
---|---|---|---|---|---|---|---|
Positive | Negative | Null | Unclear | Total | |||
Alcohol | |||||||
Alcohol intoxication (n =10) | Suicidal ideation | Bivariate | 0 | 0 | 0 | 4 | |
Multivariate | 0 | 0 | 6 | ||||
Non-fatal suicidal behaviour | Bivariate | 1 [33] | 0 | 1 [34] | 0 | 2 | |
Fatal suicide | Bivariate | 1 [35] | 0 | 0 | 0 | 1 | |
Multivariate | 1 [35] | 0 | 1 [35] | 4 | |||
Alcohol use (n = 33) | Suicidal ideation | Bivariate | 0 | 0 | 13 | ||
Multivariate | 0 | 0 | 11 | ||||
Non-fatal suicidal behaviour | Bivariate | 0 | 0 | 15 | |||
Multivariate | 1 [54] | 0 | 12 | ||||
Pathological alcohol use (n = 37) | Suicidal ideation | Bivariate | 0 | 0 | 7 | ||
Multivariate | 0 | 0 | 10 | ||||
Non-fatal suicidal behaviour | Bivariate | 0 | 0 | 27 | |||
Pathological alcohol use (n = 37) | Non-fatal suicidal behaviour | Multivariate | 0 | 0 | 18 | ||
Fatal suicide | Bivariate | 0 | 0 | 0 | 5 | ||
Multivariate | 0 | 0 | 0 | 2 | |||
Tobacco | |||||||
Tobacco use (n = 29) | Suicidal ideation | Bivariate | 0 | 0 | 13 | ||
Multivariate | 0 | 13 | |||||
Non-fatal suicidal behaviour | Bivariate | 0 | 0 | 18 | |||
Multivariate | 0 | 1 [50] | 9 | ||||
Pathological tobacco use (n = 13) | Suicidal ideation | Bivariate | 0 | 1 [92] | 1 [60] | 6 | |
Multivariate | 0 | 1 [88] | 0 | 4 | |||
Non-fatal suicidal behaviour | Bivariate | 0 | 0 | 9 | |||
Multivariate | 0 | 1 [94] | 0 | 5 | |||
Cannabis | |||||||
Cannabis use (n = 8) | Suicidal ideation | Bivariate | 1 [59] | 1 [69] | 5 | ||
Non-fatal suicidal behaviour | Bivariate | 0 | 0 | 4 | |||
Multivariate | 1 [66] | 1 [57] | 1 [57] | 0 | 3 | ||
Cannabis | |||||||
Pathological cannabis use (n = 2) | Suicidal ideation | Bivariate | 0 | 0 | 1 [89] | 0 | 1 |
Non-fatal suicidal behaviour | Bivariate | 0 | 1 [89] | 0 | 3 | ||
Multivariate | 1 [97] | 0 | 0 | 0 | 1 | ||
Cannabis and Mandrax (smoked together) | |||||||
Cannabis and Mandrax (smoked together) use (n = 1) | Non-fatal suicidal behaviour | Multivariate | 1 [66] | 0 | 0 | 0 | 1 |
Opioid | |||||||
Opioid use (n = 4) | Suicidal ideation | Multivariate | 1 [98] | 0 | 0 | 0 | 1 |
Non-fatal suicidal behaviour | Bivariate | 0 | 0 | 0 | 2 | ||
Multivariate | 0 | 0 | 0 | 2 | |||
Pathological opioid use (n = 1) | Non-fatal suicidal behaviour | Multivariate | 1 [99] | 0 | 0 | 0 | 1 |
Sedatives | |||||||
Sedative use (n = 5) | Suicidal ideation | Bivariate | 0 | 0 | 0 | 1 [60] | 1 |
Multivariate | 0 | 0 | 0 | 2 | |||
Non-fatal suicidal behaviour | Bivariate | 1 [60] | 0 | 1 [100] | 0 | 2 | |
Multivariate | 0 | 0 | 0 | 2 | |||
Pathological sedative use (n = 1) | Suicidal ideation | Bivariate | 1 [89] | 0 | 0 | 0 | 1 |
Multivariate | 1 [89] | 0 | 0 | 0 | 1 | ||
Non-fatal suicidal behaviour | Bivariate | 1 [89] | 0 | 0 | 0 | 1 | |
Multivariate | 1 [89] | 0 | 0 | 0 | 1 | ||
Stimulants | |||||||
Stimulant use (n = 4) | Non-fatal suicidal behaviour | Bivariate | 0 | 0 | 1 [70] | 0 | 1 |
Multivariate | 0 | 0 | 0 | 3 | |||
Unspecified prescription medication | |||||||
Use of unspecified prescription medication (n = 3) | Suicidal ideation | Multivariate | 0 | 0 | 0 | 2 | |
Non-fatal suicidal behaviour | Multivariate | 0 | 0 | 0 | 2 | ||
Inhalants | |||||||
Inhalants use (n = 1) | Non-fatal suicidal behaviour | Multivariate | 1 [66] | 0 | 0 | 0 | 1 |
Pathological inhalant use (n = 1) | Suicidal ideation | Bivariate | 0 | 0 | 1 [89] | 0 | 1 |
Non-fatal suicidal behaviour | Bivariate | 1 [89] | 0 | 1 [89] | 0 | 2 | |
Multivariate | 1 [89] | 0 | 0 | 0 | 0 | ||
Hallucinogens | |||||||
Hallucinogens use (n = 2) | Non-fatal suicidal behaviour | Bivariate | 1 [66] | 0 | 1 [70] | 0 | 2 |
Total | Suicidal ideation | Bivariate | 38 | 0 | 11 | 3 | 52 |
Multivariate | 33 | 0 | 13 | 2 | 48 | ||
Non-fatal suicidal behaviour | Bivariate | 58 | 0 | 30 | 0 | 88 | |
Multivariate | 42 | 2 | 17 | 1 | 62 | ||
Fatal suicide | Bivariate | 6 | 0 | 0 | 0 | 6 | |
Multivariate | 3 | 0 | 2 | 1 | 6 |
Substance use dimension | Suicide dimension | Analysis | Association between substances and suicide | ||||
---|---|---|---|---|---|---|---|
Positive | Negative | Null | Unclear | Total | |||
Substance intoxication (n = 1) | Non-fatal suicidal behaviour | Bivariate | 1 [104] | 0 | 0 | 0 | 1 |
Substance use (n = 19) | Suicidal ideation | Bivariate | 0 | 1 [105] | 12 | ||
Multivariate | 0 | 1 [50] | 12 | ||||
Non-fatal suicidal behaviour | Bivariate | 0 | 1 [50] | 10 | |||
Multivariate | 0 | 1 [51] | 7 | ||||
Pathological substance use (n = 37) | Suicidal ideation | Bivariate | 0 | 1 [92] | 0 | 3 | |
Multivariate | 0 | 0 | 9 | ||||
Non-fatal suicidal behaviour | Bivariate | 0 | 0 | 24 | |||
Multivariate | 0 | 0 | 17 | ||||
Fatal suicide | Bivariate | 1 [109] | 0 | 0 | 3 | ||
Multivariate | 1 [108] | 0 | 0 | 0 | 1 | ||
Total | Suicidal ideation | Bivariate | 10 | 0 | 2 | 3 | 15 |
Multivariate | 14 | 0 | 6 | 1 | 21 | ||
Non-fatal suicidal behaviour | Bivariate | 23 | 0 | 11 | 1 | 35 | |
Multivariate | 12 | 0 | 11 | 1 | 24 | ||
Fatal suicide | Bivariate | 1 | 0 | 2 | 0 | 3 | |
Multivariate | 1 | 0 | 0 | 0 | 1 |